These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19593439)

  • 1. Exploration of the one-bead one-compound methodology for the design of prolyl oligopeptidase substrates.
    Comellas G; Kaczmarska Z; Tarragó T; Teixidó M; Giralt E
    PLoS One; 2009 Jul; 4(7):e6222. PubMed ID: 19593439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prolyl oligopeptidase family.
    Polgár L
    Cell Mol Life Sci; 2002 Feb; 59(2):349-62. PubMed ID: 11915948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor.
    Tarragó T; Kichik N; Claasen B; Prades R; Teixidó M; Giralt E
    Bioorg Med Chem; 2008 Aug; 16(15):7516-24. PubMed ID: 18650094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboxypeptidase in prolyl oligopeptidase family: Unique enzyme activation and substrate-screening mechanisms.
    Yadav P; Goyal VD; Gaur NK; Kumar A; Gokhale SM; Jamdar SN; Makde RD
    J Biol Chem; 2019 Jan; 294(1):89-100. PubMed ID: 30409909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues about the physiological functions of prolyl oligopeptidase based on its discordant spatial association with substrates and inconsistencies among mRNA, protein levels, and enzymatic activity.
    Myöhänen TT; García-Horsman JA; Tenorio-Laranga J; Männistö PT
    J Histochem Cytochem; 2009 Sep; 57(9):831-48. PubMed ID: 19687473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural product berberine is a human prolyl oligopeptidase inhibitor.
    Tarrago T; Kichik N; Seguí J; Giralt E
    ChemMedChem; 2007 Mar; 2(3):354-9. PubMed ID: 17295371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidomics of prolyl endopeptidase in the central nervous system.
    Nolte WM; Tagore DM; Lane WS; Saghatelian A
    Biochemistry; 2009 Dec; 48(50):11971-81. PubMed ID: 19911840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of the prolyl oligopeptidase homologue from Pyrococcus furiosus.
    Juhász T; Szeltner Z; Polgár L
    FEBS Lett; 2006 Jun; 580(14):3493-7. PubMed ID: 16714022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The noncatalytic beta-propeller domain of prolyl oligopeptidase enhances the catalytic capability of the peptidase domain.
    Szeltner Z; Renner V; Polgár L
    J Biol Chem; 2000 May; 275(20):15000-5. PubMed ID: 10747969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of peptide-based prolyl oligopeptidase inhibitors--introduction of N-benzyloxycarbonyl-prolyl-3-fluoropyrrolidine as a lead in inhibitor design.
    Goossens F; Vanhoof G; De Meester I; Augustyns K; Borloo M; Tourwe D; Haemers A; Scharpé S
    Eur J Biochem; 1997 Nov; 250(1):177-83. PubMed ID: 9432007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α.
    Jambunathan K; Watson DS; Endsley AN; Kodukula K; Galande AK
    FEBS Lett; 2012 Jul; 586(16):2507-12. PubMed ID: 22750443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity determination of mouse implantation serine proteinase and human kallikrein-related peptidase 6 by phage display.
    Sharma N; Oikonomopoulou K; Ito K; Renaux B; Diamandis EP; Hollenberg MD; Rancourt DE
    Biol Chem; 2008 Aug; 389(8):1097-105. PubMed ID: 18979633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing of the phalloidin proprotein by prolyl oligopeptidase from the mushroom Conocybe albipes.
    Luo H; Hallen-Adams HE; Walton JD
    J Biol Chem; 2009 Jul; 284(27):18070-7. PubMed ID: 19389704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-α for different indications.
    Plescia J; Hédou D; Pousse ME; Labarre A; Dufresne C; Mittermaier A; Moitessier N
    Eur J Med Chem; 2022 Oct; 240():114543. PubMed ID: 35797897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis.
    Tenorio-Laranga J; Coret-Ferrer F; Casanova-Estruch B; Burgal M; García-Horsman JA
    J Neuroinflammation; 2010 Apr; 7():23. PubMed ID: 20370893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors.
    Babkova K; Korabecny J; Soukup O; Nepovimova E; Jun D; Kuca K
    Future Med Chem; 2017 Jun; 9(10):1015-1038. PubMed ID: 28632451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence resonance energy transfer (FRET) peptides and cycloretro-inverso peptides derived from bradykinin as substrates and inhibitors of prolyl oligopeptidase.
    Gorrão SS; Hemerly JP; Lima AR; Melo RL; Szeltner Z; Polgár L; Juliano MA; Juliano L
    Peptides; 2007 Nov; 28(11):2146-54. PubMed ID: 17904692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hunting for peptide substrates of prolyl oligopeptidase: classical versus non-classical bioactive peptides.
    Tenorio-Laranga J; Männistö PT; García-Horsman JA
    CNS Neurol Disord Drug Targets; 2011 May; 10(3):319-26. PubMed ID: 21222622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization and subcellular distribution of prolyl oligopeptidase in the mouse placenta.
    Matsubara S; Takahashi T; Kimura AP
    J Mol Histol; 2011 Jun; 42(3):251-64. PubMed ID: 21544597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery.
    Rosenblum JS; Kozarich JW
    Curr Opin Chem Biol; 2003 Aug; 7(4):496-504. PubMed ID: 12941425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.